Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)
Clinical trial NCT04060199 · COMPLETED
Trial details
- NCT number
- NCT04060199
- Sponsor
- NS Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-14
- Primary completion
- 2023-10-19
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.